Investor activity regarding Corcept Therapeutics, including RBC boosting holdings and Amundi buying, was disclosed via SEC filings.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Investor activity regarding Corcept Therapeutics, including RBC boosting holdings and Amundi buying, was disclosed via SEC filings.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Corcept Therapeutics disclosed insider trading activity via SEC filings.Sub-event
Details of investor buying and insider sales in Corcept Therapeutics stock revealed in SEC filings.1 source
Keep exploring
The entities involved
-
Corcept Therapeutics
American pharmaceutical company
-
Royal Bank of Canada
financial institution in Canada
-
SEC
Slovak company
Related events
- Houlihan Lokey disclosed insider trading via SEC filing while Royal Bank of Canada increased its stake in the company's stock.
- Royal Bank of Canada increased its investment holdings in Invmun Incom stock on September 2, 2026.
- RBC increased its stake in Navient, filing the necessary 13F reports with the SEC.
- Royal Bank of Canada acquired a new stake in the JPMorgan ActiveBuilders Emerging Markets Equity ETF.
- Royal Bank of Canada increased its stake in Olin Corporation stock.